Kankerpatiënten in India hebben grote moeite essentiële geneesmiddelen op basis van platina te vinden. Dat komt door problemen met levering en de sterk gestegen prijzen. Sommige fabrikanten hebben de productie verlaagd of zelfs stopgezet.
Indiase kankerpatiënten kampen met tekort medicijnen door prijsstijging platina
Kankerpatiënten in India hebben grote moeite essentiële geneesmiddelen op basis van platina te vinden.
Dat komt door problemen met levering en de sterk gestegen prijzen.
Sommige fabrikanten hebben de productie verlaagd of zelfs stopgezet.
Platinageneesmiddelen zijn krachtige celdodende medicijnen die worden gebruikt bij chemotherapie om kanker te bestrijden.
Indian cancer patients battle shortage of key drugs as platinum costs surge
Cancer patients battle shortage of key drugs as platinum costs surge
India raises price cap on cancer drugs to tackle shortage
Regulator, cos discuss price hike for some cancer drugs
India hikes cancer drug prices by 50% amid shortages
Cancer: NPPA raises price cap on key drugs amid shortage
Government may lift price cap on cancer drugs making them costlier by up to 50%
Cancer drug prices raised 50% as NPPA acts on shortage concerns
Price cap on cancer drugs increase to tackle shortage
NPPA hikes Cisplatin and Carboplatin prices by 50% amid cancer drug shortage
Cancer patients in India are struggling to find essential platinum-based drugs. A surge in global platinum prices and supply…
Cancer patients in India face a severe shortage of platinum-based drugs due to rising costs and supply disruptions.
India's drug price regulator has increased the ceiling prices of cancer drugs cisplatin and carboplatin by 50% to tackle…
India's drug pricing authority may soon approve a price hike for vital platinum-based cancer medicines. These drugs, including…
India's NPPA approved a 50% price hike for carboplatin and cisplatin, citing rising platinum costs, to address accessibility…
India raises price caps on key cancer drugs by 50% to address shortages caused by rising raw material costs.
